Rapid and accurate assessment of GPCR–ligand interactions Using the fragment molecular orbital‐based density‐functional tight‐binding method

The reliable and precise evaluation of receptor–ligand interactions and pair‐interaction energy is an essential element of rational drug design. While quantum mechanical (QM) methods have been a promising means by which to achieve this, traditional QM is not applicable for large biological systems due to its high computational cost. Here, the fragment molecular orbital (FMO) method has been used to accelerate QM calculations, and by combining FMO with the density‐functional tight‐binding (DFTB) method we are able to decrease computational cost 1000 times, achieving results in seconds, instead of hours. We have applied FMO‐DFTB to three different GPCR–ligand systems. Our results correlate well with site directed mutagenesis data and findings presented in the published literature, demonstrating that FMO‐DFTB is a rapid and accurate means of GPCR–ligand interactions. © 2017 Authors. Journal of Computational Chemistry Published by Wiley Periodicals, Inc.

[1]  Philip C. Biggin,et al.  Using the fragment molecular orbital method to investigate agonist–orexin-2 receptor interactions , 2016, Biochemical Society transactions.

[2]  Ralf C. Kling,et al.  GPCR crystal structures: Medicinal chemistry in the pocket. , 2015, Bioorganic & medicinal chemistry.

[3]  Philip C Biggin,et al.  Guiding lead optimization with GPCR structure modeling and molecular dynamics. , 2016, Current opinion in pharmacology.

[4]  Ali Jazayeri,et al.  From G Protein-coupled Receptor Structure Resolution to Rational Drug Design* , 2015, The Journal of Biological Chemistry.

[5]  Steven M. Moss,et al.  Structure of the human P2Y12 receptor in complex with an antithrombotic drug , 2014, Nature.

[6]  Michael Gaus,et al.  Parameterization of DFTB3/3OB for Sulfur and Phosphorus for Chemical and Biological Applications , 2014, Journal of chemical theory and computation.

[7]  Dmitri G. Fedorov,et al.  Three‐body expansion of the fragment molecular orbital method combined with density‐functional tight‐binding , 2017, J. Comput. Chem..

[8]  M. Elstner,et al.  Parametrization and Benchmark of DFTB3 for Organic Molecules. , 2013, Journal of chemical theory and computation.

[9]  Kazuo Kitaura,et al.  The importance of three-body terms in the fragment molecular orbital method. , 2004, The Journal of chemical physics.

[10]  S. Rasmussen,et al.  Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.

[11]  Younis Baqi,et al.  Interaction of New, Very Potent Non-Nucleotide Antagonists with Arg256 of the Human Platelet P2Y12 Receptor , 2009, Journal of Pharmacology and Experimental Therapeutics.

[12]  S. Kunapuli,et al.  Central role of the P2Y12 receptor in platelet activation. , 2004, The Journal of clinical investigation.

[13]  Michael Gaus,et al.  Density functional tight binding: application to organic and biological molecules , 2014 .

[14]  Mark S. Gordon,et al.  General atomic and molecular electronic structure system , 1993, J. Comput. Chem..

[15]  Kazuo Kitaura,et al.  CH/π hydrogen bonds play a role in ligand recognition and equilibrium between active and inactive states of the β2 adrenergic receptor: an ab initio fragment molecular orbital (FMO) study. , 2011, Bioorganic & medicinal chemistry.

[16]  Kazuo Kitaura,et al.  Exploring chemistry with the fragment molecular orbital method. , 2012, Physical chemistry chemical physics : PCCP.

[17]  Yoshio Nishimoto,et al.  The fragment molecular orbital method combined with density-functional tight-binding and the polarizable continuum model. , 2016, Physical chemistry chemical physics : PCCP.

[18]  Bryan L. Roth,et al.  Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.

[19]  Michael J. Bodkin,et al.  The Fragment Molecular Orbital Method Reveals New Insight into the Chemical Nature of GPCR-Ligand Interactions , 2016, J. Chem. Inf. Model..

[20]  Alan Wise,et al.  Target validation of G-protein coupled receptors. , 2002, Drug discovery today.